関連する実験動画

Updated: Sep 9, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.6K

再発性/転移性頭頸部状細胞癌の全生存率は,全身治療の1回以上後に進行し,新しい細胞封じ込みベースの免疫療法であるMVX-ONCO-1で治療された患者:第2相IIa試験SAKK 11/16の結果

Eugenio Fernandez1,2, Rémi Vernet1,3,2, Muriel Urwyler1,3,2

  • 1Division of Oncology, Geneva University Hospitals, Geneva, Switzerland.

Experimental hematology & oncology
|August 31, 2025
PubMed
まとめ

独生腫瘍細胞とGM-CSFを組み合わせた新しいがんワクチンMVX-ONCO-1は,頭頸部がん患者における有望な生存率を示した. このパーソナライズされたワクチンは 協調した免疫反応を誘発し 単独の治療として臨床的利点を提供しました

キーワード:
進行した固体腫瘍オートログの放射線を受けた腫瘍細胞細胞封装装置粒細胞マクロファージコロニーの刺激因子免疫療法

さらに関連する動画

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

9.9K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.6K

関連する概念動画

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448